0 Yorumlar
0 hisse senetleri
522 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
In Vivo CRO Market to Reach USD 10.07 Billion by 2033, Driven by Growing Global Research StandardsThe global in vivo CRO market size was valued at USD 4.95 billion in 2024, and it is projected to reach USD 5.36 billion in 2025 to USD 10.07 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025–2033). The rising international standards adoption by contract researchers in emerging nations is projected to improve demand for...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Clinical Trials SMO Market to Reach USD 3.2 Billion by 2034 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global Clinical Trials Site Management Organizations (SMO) market was valued at USD 1.84 billion in 2025 and is projected to reach USD 3.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2026–2034. Clinical Trials Site Management Organizations are specialized...0 Yorumlar 0 hisse senetleri 558 Views 0 önizleme
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Yorumlar 0 hisse senetleri 82 Views 0 önizleme
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Yorumlar 0 hisse senetleri 75 Views 0 önizleme
Sponsorluk
Sponsorluk